Translational Medicine: Interdisciplinary Molecular Medicine (MRes )
View tabbed content | View all content (for printing)
Teaching and learning
The Masters by Research in Translational Medicine (Interdisciplinary Molecular Medicine) provides broad training in biotechnology for medical healthcare. Teaching comprises four taught modules (delivered using a variety of face-to-face, workshop and e-learning approaches) before students undertake an extended 35-week research project. Our trainingensures that our graduates are well equipped to progress into careers in both academia and the Pharmaceutical or Biotechnology Industries.
A wide choice of projects are available allowing individuals to focus on areas of interest such as the use of gene expression profiling, proteomics, metabolomics stem cell research, tissue culture or pharmacogenetics in the biology of cancer, cardiovascular disease, stroke or diabetes.
Examples of research projects:
- Using silk as a biomaterial for nerve regeneration
- Species variability in metabolism as a translational factor influencing susceptibility to adverse drug reactions in man
- The function of Notch signalling in vascular smooth muscle cell differentiation from mouse embryonic stem cells
- Statins in translational cerebral ischemia: systematic review and meta-analysis of pre-clinical studies
- Parallel gene expression profiling and histological analysis of tumour tissue microarrays
- Metabonomic profiling of tumour-bearing mice
- Research Project Outputs and further research project examples
Progression and assessment
The Masters of Research employs a wide range of teaching and assessment methods to promote a stimulating, challenging and dynamic environment that will equip you for your future career in the Pharmaceutical or Biotechnology industries, or for further PhD study in academia or as an academic clinician.
Students are assessed through oral and poster presentations, workshops, literature review, written reports and a journal article dissertation.
The Masters of Research is carried out within state-of-the-art University of Manchester academic research facilities including the Manchester Institute for Biotechnology (MIB) , Michael Smith and AV Hill Buildings. The MIB is equipped with state-of-the-art facilities for training in biotechnologies for medical healthcare.
Research projects are carried out within the University of Manchester, AstraZeneca or one of the Greater Manchester Teaching Hospitals.
The University of Manchester has embarked on the largest capital investment programme ever undertaken in UK higher education in state-of-the-art buildings and major refurbishments. Students on the MRes therefore benefit from this unique environment and the wealth of facilities available.